描述暴力干预街道外展参与者和服务剂量:对测量和评估的影响
Marisa C Ross1, Susan Burtner1, Andrew V Papachristos1
1Northwestern University, Evanston, IL, USA.
Inquiry : a journal of medical care organization, provision and financing
|September 29, 2025
概括
社区暴力干预街头宣传 (CVI-SO) 计划根据参与者的风险量身定制服务,包括长期指导. 风险较高的个人获得更密集的支持,展示了减少枪支暴力的适应性策略.
科学领域:
- 公共卫生 公共卫生
- 犯罪学 犯罪学
- 社会工作 社会工作 社会工作
背景情况:
- 社区暴力干预街头宣传 (CVI-SO) 是对枪支暴力的日益增长的非惩罚性方法.
- 关于CVI-SO有效性的证据因文档,数据隐私,选择偏见和参与者变化而混合.
- 有效的评估需要了解服务范围,交付和基于个体特征的变化.
研究的目的:
- 探索芝加哥CVI联盟 (2017-2023) 参与者获得的服务.
- 检查人口统计,风险因素和服务提供/剂量中的模式.
- 描述典型的参与者,并确定服务交付变化.
主要方法:
- 分析了来自4000多名参与者和近20万次互动的行政和程序数据.
- 描述性和潜在的个人资料分析,以确定参与者群体和服务模式.
- 检查人口统计,基于网络的风险因素和服务剂量.
主要成果:
- 在CVI的工作中,很大程度上依赖于长期的指导关系.
- 确定了具有不同服务剂量的潜伏组.
- 风险较高的参与者接受了更频繁,更长期的联系,表明适应性服务提供.
- 显而易见的个人资料出现了:低剂量,中剂量和行为服务.
结论:
- 根据参与者的风险和需求,CVI组织在战略上根据参与者的风险和需求来改变服务提供.
- 通过CVI项目影响结果存在多种途径.
- 评估框架必须捕捉战略服务变化和多样化的影响途径.
相关概念视频
Group Design
10.2K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.2K
Community Based Intervention
277
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
277
Dosage Regimens: Designs and Approaches
263
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
263
Impact of Individuals on Individuals
356
Human behavior is intricately shaped by social influences that arise from interactions with others in diverse contexts. These influences not only mold beliefs and attitudes but also drive the regulation of behaviors through both direct communication and observational learning. The study of these processes falls within the domain of social psychology, which seeks to understand how individuals are affected by and affect those around them.Mechanisms of Social InfluenceDirect social influence...
356
Agonism and Antagonism: Quantification
983
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
983
Dose-Response Relationship: Potency and Efficacy
6.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.3K


